Herpes simplex virus in children

被引:13
作者
Richard J. Whitley
机构
[1] Children’s Hospital at the University of Alabama at Birmingham,
关键词
Herpes Simplex Virus; Acyclovir; Main Side Effect; Main Drug Interaction; Herpes Simplex Encephalitis;
D O I
10.1007/s11940-002-0040-2
中图分类号
学科分类号
摘要
Herpes simplex virus (HSV) infections are ubiquitous. Children are infected with HSV resulting in totally asymptomatic acquisition to life-threatening disease. Therapy of HSV diseases of children can be considered according to severity and time of acquisition [1].Neonatal herpes simplex virus infections take one of three forms—disease localized to skin, eye, or mouth (SEM), encephalitis, or multiorgan disseminated disease. Treatment consists of intravenous (IV) administration of acyclovir. Supportive care for patients with life-threatening disease is an integral component of patient management.Mucocutaneous HSV infections in the immunocompromised host can be treated with either intravenous acyclovir or one of the orally bioavailable antiviral therapies. For hospitalized patients, therapy consists of IV acyclovir at 5 mg/kg every 8 hours for 7 to 14 days. For ambulatory patients, therapy is tailored according to age. For children less than 12 years of age, oral acyclovir is administered at a dosage of 20 mg/kg every eight hours. Although no controlled studies have been performed with valaciclovir or famciclovir, the pharmacokinetics of these medications would suggest superiority over acyclovir. Dosage recommendations have not been established for young children. For postpubertal children, dosage should mirror that of adults. Valaciclovir is administered at 500 mg twice daily. Famciclovir is administered at 125 mg three times daily.Herpes simplex keratoconjunctivitis is treated with topical triflurothymidine. Two drops are applied to the infected eye five times daily until resolved. Recurrences are managed in a similar manner. Some physicians administer oral acyclovir at the doses noted above in order to prevent frequent recurrences.Genital HSV infections can be treated with acyclovir, valaciclovir, or famciclovir. Episodic treatment of recurrent episodes is usually not necessary in childhood. Importantly, all data on the use of these compounds for these conditions have been generated in adults.Physician judgment is required for the management of recurrent herpes labialis, erythema multiforme, and herpes gladitorum. No controlled studies have been performed in children, although experience with acyclovir, valaciclovir, and famciclovir have resulted in their use.
引用
收藏
页码:231 / 237
页数:6
相关论文
共 38 条
[1]  
Balfour HH(1999)Antiviral drugs N Engl J Med 340 1255-1268
[2]  
Whitley RJ(2001)Herpes simplex viruses: from structure to function Lancet 357 1513-1513
[3]  
Roizman B(1991)A controlled trial comparing vidarabine with acyclovir in neonatal herpes simplex virus infection N Engl J Med 324 444-449
[4]  
Whitley RJ(1991)Predictors of morbidity and mortality in neonates with herpes simplex virus infections N Engl J Med 324 450-454
[5]  
Arvin A(2001)The safety and efficacy of high-dose intravenous acyclovir in the management of neonatal herpes simplex virus infections Pediatrics 108 230-238
[6]  
Prober C(2001)Natural history of neonatal herpes simplex virus infections in the acyclovir era Pedatrics 108 223-229
[7]  
Whitley RJ(1986)Vidarabine versus acyclovir therapy in herpes simplex encephalitis N Engl J Med 314 144-149
[8]  
Arvin A(1984)Acyclovir versus vidarabine in herpes simplex encephalitis: a randomized multicentre study in consecutive Swedish patients Lancet 2 707-711
[9]  
Prober C(2000)Valaciclovir: a review of its long term utility in the management of genital herpes simplex virus and cytomegalovirus infections Drugs 59 839-863
[10]  
Kimberlin DW(1996)Valaciclovir: a review of its antiviral, pharmacokinetic properties and therapeutic efficacy in herpesvirus infections Drugs 52 754-772